Assura appoints Ed Smith to the Board as Non-Executive Director

– UK, Warrington – Assura plc (LSE:AGR), the leading investor and developer of primary care properties, announces today that Ed Smith has been appointed to the Board as Non-Executive Director with immediate effect.

Ed Smith was Chairman of NHS Improvement for three years and the Lead Non-Executive Director for the Department for Transport until the end of December 2017. He is also the Pro-Chancellor and Chairman of Council at the University of Birmingham. He was the former Global Assurance Chief Operating Officer and Strategy Chairman of PricewaterhouseCoopers (PwC). Before retiring from PwC, he had a 30-year career as a Senior Partner, holding many leading board and top client roles in the UK and globally.

Simon Laffin, Chairman of Assura, commented: “Ed’s wealth of business experience, in both private and public sectors, will stand us in good stead as Assura continues to fund the transformation of NHS primary care premises.”

Commenting on his appointment, Ed Smith said: “Assura provides excellent facilities for NHS primary care and I look forward to being involved in Assura’s continued growth and performance over the next few years.”

About Assura plc

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2017, Assura’s property portfolio was valued at £1,345 million.

For more information : https://www.assuraplc.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.